Skip to main content

Biology of Osteosarcoma

  • Chapter
  • First Online:
  • 2560 Accesses

Abstract

Unlike other sarcomas, osteosarcoma (OS) is characterized by complex, unbalanced karyotypes and alterations in multiple genes and pathways. This genetic background originates from the high genetic instability of OS cells, which can lead to multiple malignant cell populations within the same tumor (Hattinger et al. 2010; Atiye et al. 2005).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Bibliography

  • Atiye J, Wolf M, Kaur S, Monni O, Bohling T, Kivioja A, Tas E, Serra M, Tarkkanen M, Knuutila S (2005) Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42:158–163

    Article  CAS  PubMed  Google Scholar 

  • Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, Serra M (1995) Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 333:1380–1385

    Article  CAS  PubMed  Google Scholar 

  • Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM (2011) Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents. Clin Cancer Res 17:2110–2119

    Article  CAS  PubMed  Google Scholar 

  • Hattinger CM, Reverter-Branchat G, Remondini D, Castellani G, Benini S, Pasello M, Manara MC, Scotlandi K, Picci P, Serra M (2003) Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. Eur J Cell Biol 82:483–493

    Article  CAS  PubMed  Google Scholar 

  • Hattinger CM, Stoico G, Michelacci F, Pasello M, Scionti I, Remondini D, Castellani GC, Fanelli M, Scotlandi K, Picci P, Serra M (2009) Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. Genes Chromosomes Cancer 48:289–309

    Article  CAS  PubMed  Google Scholar 

  • Hattinger CM, Pasello M, Ferrari S, Picci P, Serra M (2010) Emerging drugs for high-grade osteosarcoma. Expert Opin Emerg Drugs 15:615–634

    Article  CAS  PubMed  Google Scholar 

  • Pasello M, Michelacci F, Scionti I, Hattinger CM, Zuntini M, Caccuri AM, Scotlandi K, Picci P, Serra M (2008) Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Cancer Res 68:6661–6668

    Article  CAS  PubMed  Google Scholar 

  • Scionti I, Michelacci F, Pasello M, Hattinger CM, Alberghini M, Manara MC, Bacci G, Ferrari S, Scotlandi K, Picci P, Serra M (2008) Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. Ann Oncol 19:1500–1508

    Article  CAS  PubMed  Google Scholar 

  • Serra M, Scotlandi K, Manara MC, Maurici D, Benini S, Sarti M, Campanacci M, Baldini N (1995) Analysis of P-glycoprotein expression in osteosarcoma. Eur J Cancer 12:1998–2002

    Article  Google Scholar 

  • Serra M, Scotlandi K, Reverter-Branchat G, Ferrari S, Manara MC, Benini S, Incaprera M, Bertoni F, Mercuri M, Briccoli A, Bacci G, Picci P (2003) Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. J Clin Oncol 21:536–542

    Article  CAS  PubMed  Google Scholar 

  • Serra M, Pasello M, Manara MC, Scotlandi K, Ferrari S, Bertoni F, Mercuri M, Alvegard TA, Picci P, Bacci G, Smelalnd S (2006) May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol. Int J Oncol 29:1459–1468

    CAS  PubMed  Google Scholar 

  • Toffoli G, Biason P, Russo A, De Mattia E, Cecchin E, Hattinger CM, Pasello M, Alberghini M, Ferrari C, Scotlandi K, Picci P, Serra M (2009) Impact of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high grade osteosarcoma development and survival. Clin Cancer Res 15:3550–3556

    Article  CAS  PubMed  Google Scholar 

  • Wolf M, El-Rifai W, Tarkkanen M, Kononen J, Serra M, Eriksen EF, Elomaa I, Kallionemi A, Kallionemi O-P, Knuutila S (2000) Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet Cytogenet 123:128–132

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Serra PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Serra, M. (2014). Biology of Osteosarcoma. In: Picci, P., Manfrini, M., Fabbri, N., Gambarotti, M., Vanel, D. (eds) Atlas of Musculoskeletal Tumors and Tumorlike Lesions. Springer, Cham. https://doi.org/10.1007/978-3-319-01748-8_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-01748-8_43

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-01747-1

  • Online ISBN: 978-3-319-01748-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics